Plain-English translation of NCT06100328 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a long-term research study that gathers information about different types of heart tumors—both benign (non-cancerous) and malignant (cancerous)—to better understand how they behave and affect patients over time. Researchers are looking at medical records and patient histories from the past 20 years, and will continue following new patients through 2030. The goal is to learn what happens to patients with heart tumors and how doctors can predict which patients are at higher risk for serious problems.
Heart tumors are rare, and doctors need better information to understand which patients will do well and which ones might have complications. By studying many patients in different hospitals, researchers hope to create tools that help doctors predict outcomes and decide on the best treatment for each patient.
You likely qualify if…
You likely don't qualify if…
If you join this study, researchers will review your medical records and heart imaging to understand your tumor and how it is progressing. You will continue with your regular follow-up appointments at your heart center, and the study team will track your health information over many years. There is no new medication or surgery required—this is purely an information-gathering study to help doctors learn from your experience.
AI-generated summary from trial data · Aug 24, 2026 · Not medical advice
China
Sponsor
First Affiliated Hospital Xi'an Jiaotong University
Enrollment target
~40 participants
Started
October 2023
Primary completion
July 2030
Age range
3 Years – 80 Years
Last updated on clinicaltrials.gov in July 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Guoliang Li
First Affiliated Hospital Xi'an Jiaotong University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.